🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Spero Therapeutics, Inc.

Spero Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Tebipenem pivoxil hydrobromide (HBr), SPR206, SPR720

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for multi-drug resistant bacterial infections and rare diseases in the United States.

Tags: MDR infections, antibiotics, biopharmaceutical, clinical-stage, healthcare, rare diseases

Symbol: SPRO

Recent Price: $1.02

Industry: Biotechnology

CEO: Mr. Satyavrat Shukla C.F.A.

Sector: Healthcare

Employees: 46

Address: 675 Massachusetts Avenue, Cambridge, MA 02139

Phone: 857 242 1600

Leadership

  • Sath Shukla, President and Chief Executive Officer
  • Esther Rajavelu, Chief Financial Officer and Chief Business Officer
  • Timothy Keutzer, Chief Operating Officer
  • James P. Brady, Chief Human Resource Officer
  • Ankit Mahadevia, MD, Chairperson
  • Cynthia Smith, Compensation Committee Chair
  • Frank E. Thomas, Audit Committee Chair
  • Patrick Vink, MD, Nominating and Corporate Governance Chair
  • Milind Deshpande, PhD, Nominating and Corporate Governance Committee Member, Audit Committee Member, and Development Committee Member
  • Scott Jackson, Nominating and Corporate Governance Member and Audit Committee Member
  • John C. Pottage, Jr., M.D., Development Committee Chair
  • Kathleen Tregoning, Compensation Committee Member

Last updated: 2024-12-31